LSZ 150 mcg Blotters (Lysergic Acid Derivative) – Scientific Product Description

Introduction

LSZ (Lysergic Acid 2,4-dimethylazetidide) is a semi-synthetic lysergamide, structurally related to LSD. These 150 mcg blotters were developed for use in strictly controlled laboratory environments and are intended for research into the pharmacological properties ou psychedelic compounds. Production takes place under strict quality control.

Spécifications techniques

• Active ingredient: LSZ (Lysergic Acid 2,4-dimethylazetidide)
• Dosage per blotter: 150 ± 5 mcg
• Blotter size: 5×5 mm, perforated squares
• Carrier medium: High-quality chromatography paper
• Pureté : ≥98% (analysé par HPLC)
• Shelf life: 24 months when stored between 2–8°C in a light-proof container.

Applications de recherche

LSZ blotters are used in:

• Receptor binding studies targeting 5-HT2A agonism
• Comparative pharmacological analysis within the lysergamide class
• Dose-response studies in controlled models
• Metabolic stability studies in vitro

Contrôle de qualité

Chaque lot est soumis à :

• HPLC-UV quantification of active substance
• Confirmation via mass spectrometry
• Dosage uniformity analysis
• Microbiological control of the carrier material

Protocole de sécurité

Manutention

• Use nitrile gloves for all handling
• Avoid direct contact with skin
• Work only in a controlled laboratory environment
• Wear protective clothing, goggles and, if necessary, respiratory protection

Stockage

• Temperature: 2–8°C
• Protection from light and moisture is required
• Use only the original, sealed packaging

Cadre réglementaire

• Classified under the Dutch Opium Act (Schedule I)
• Only permitted for licensed research institutions
• Ne convient pas à la consommation humaine
• Export and distribution subject to regulations

Informations sur la commande

• Packaging unit: 10 blotters per sheet
• Delivery: Refrigerated transport with temperature registration
• Documentation: COA and full analytical specifications available per batch

Scientific References

• Nichols (2016) – Les psychédéliques comme médicaments
• Brandt et al. (2020) – Pharmacologie du lysergamide
• OEDT (2023) – Rapport technique sur les nouvelles substances psychoactives

Remarque importante

This product is intended solely for legally authorized scientific research. Sale and use are restricted to qualified professionals within a regulated research environment. The purchaser is solely responsible for compliance with applicable laws and regulations.

Buvards artistiques 1cP-LSD 150 MCG Granulés O-DSMT 50 mg buvards 1V-LSD 150 MCG 6-CL-ADBA Granulés de 2-CMC 250 mg